Related Experiment Video

Updated: Aug 9, 2026

Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach
09:15

Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach

Published on: May 7, 2019

De novo glomerulonephritis in renal allografts with hepatitis C virus infection

B H Ozdemir1, F N Ozdemir, S Sezer

  • 1Department of Pathology, Baskent University, Faculty of Medicine, Ankara, Turkey. handan27@hotmail.com

Transplantation Proceedings
|March 22, 2006
PubMed

Insights

Hepatitis C virus (HCV) infection significantly increases the risk of developing de novo glomerulonephritis (GN) after transplantation. HCV-positive patients with de novo GN experienced reduced graft survival, highlighting the need for vigilant monitoring.

Area of Science:

  • Nephrology
  • Virology
  • Transplant Medicine

Background:

  • Hepatitis C virus (HCV) infection is a significant concern in organ transplantation.
  • Posttransplant de novo glomerulonephritis (GN) can impact graft outcomes.

Purpose of the Study:

  • To investigate the influence of HCV infection on the development of de novo GN in renal transplant recipients.
  • To compare the incidence and outcomes of de novo GN in HCV-positive versus HCV-negative patients.

Main Methods:

  • Retrospective analysis of 165 renal transplant recipients (44 HCV-positive, 121 HCV-negative).
  • Review of kidney biopsies (light and immunofluorescence microscopy) and clinical data.
  • Statistical comparison of de novo GN incidence, graft survival, and disease recurrence rates.

Main Results:

  • HCV-positive patients had a significantly higher incidence of de novo GN (34%) compared to HCV-negative patients (6.6%).
  • De novo GN in HCV-positive recipients was associated with impaired graft survival.
  • Recurrence of primary kidney diseases was more frequent in HCV-negative patients.

Conclusions:

  • HCV infection is a major risk factor for developing de novo GN post-transplantation.
  • Close monitoring with renal biopsies is crucial for HCV-positive transplant recipients, even without overt clinical signs.
  • Understanding these associations aids in optimizing transplant management and patient outcomes.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...